The cardiac toxicity of anabolic steroids.

[1]  W. Schänzer,et al.  Metabolism of anabolic androgenic steroids. , 1996, Clinical chemistry.

[2]  D. Rittoo,et al.  MYOCARDIAL INFARCTION WITH EXTENSIVE INTRACORONARY THROMBUS INDUCED BY ANABOLIC STEROIDS , 1996, The British journal of clinical practice.

[3]  R. Melchert,et al.  Cardiovascular effects of androgenic-anabolic steroids. , 1995, Medicine and science in sports and exercise.

[4]  R. Melchert,et al.  Anabolic-androgenic steroid-induced toxicity in primary neonatal rat myocardial cell cultures. , 1995, Toxicology and applied pharmacology.

[5]  H. Tanner.  Bioenergetics in the pathogenesis, progression and treatment of cardiovascular disorders. , 1995, Medical hypotheses.

[6]  I. Prather,et al.  Sudden cardiac death in a 20-year-old bodybuilder using anabolic steroids. , 1995, Cardiology.

[7]  S. Watanabe,et al.  Two cases of acute myocardial infarction associated with aplastic anemia during treatment with anabolic steroids. , 1994, Japanese heart journal.

[8]  Michael Fisher,et al.  Myocardial infarction, hyperkalaemia and ventricular tachycardia in a young male body-builder. , 1994, International journal of cardiology.

[9]  M. Huie.  An acute myocardial infarction occurring in an anabolic steroid user. , 1994, Medicine and science in sports and exercise.

[10]  J. Marín,et al.  Chronic treatment with the anabolic steroid, nandrolone, inhibits vasodilator responses in rabbit aorta. , 1994, European journal of pharmacology.

[11]  M. Kennedy,et al.  Myocardial infarction and cerebral haemorrhage in a young body builder taking anabolic steroids. , 1993, Australian and New Zealand journal of medicine.

[12]  K. Berg,et al.  The effects of anabolic steroids on myocardial structure and cardiovascular fitness. , 1993, Medicine and science in sports and exercise.

[13]  D. Green,et al.  Anabolic steroids and vascular responses , 1993, The Lancet.

[14]  W. Kraemer,et al.  Magnetic resonance imaging determination of left ventricular mass: junior Olympic weightlifters. , 1993, Medicine and science in sports and exercise.

[15]  C. Lawrence,et al.  Anabolic steroid abuse and cardiac death , 1993, The Medical journal of Australia.

[16]  J. Ansell,et al.  Coagulation abnormalities associated with the use of anabolic steroids. , 1993, American heart journal.

[17]  R. Rockhold,et al.  Cardiovascular toxicity of anabolic steroids. , 1993, Annual review of pharmacology and toxicology.

[18]  K. Weber,et al.  Pathologic remodeling of the myocardium in a weightlifter taking anabolic steroids. , 1993, Blood pressure.

[19]  B. Littlepage,et al.  Misusing anabolic drugs. , 1992, BMJ.

[20]  S. Adelman,et al.  Myocardial infarction associated with anabolic steroid use in a previously healthy 37-year-old weight lifter. , 1992, American heart journal.

[21]  F. Hartgens,et al.  Influence of anabolic steroids on body composition, blood pressure, lipid profile and liver functions in body builders period , 1992 .

[22]  P. Walter,et al.  Diagnosis and treatment of ventricular tachycardia. , 1992, Heart disease and stroke : a journal for primary care physicians.

[23]  W. Rejeski,et al.  The effects of testosterone on lipids and eicosanoids in cynomolgus monkeys. , 1992, Medicine and science in sports and exercise.

[24]  G. Ferenchick,et al.  Androgenic-anabolic steroid abuse and platelet aggregation: a pilot study in weight lifters. , 1992, The American journal of the medical sciences.

[25]  R. Melchert,et al.  The effect of anabolic-androgenic steroids on primary myocardial cell cultures. , 1992, Medicine and science in sports and exercise.

[26]  P. Thompson,et al.  Left ventricular function is not impaired in weight-lifters who use anabolic steroids. , 1992, Journal of the American College of Cardiology.

[27]  G. Ferenchick.  Association of steroid abuse with cardiomyopathy in athletes. , 1991, The American journal of medicine.

[28]  G. Glazer,et al.  Atherogenic effects of anabolic steroids on serum lipid levels. A literature review. , 1991, Archives of internal medicine.

[29]  A. Brownie,et al.  Expression of Adrenal Cytochromes P‐450 in Testosterone‐Induced Hypertension , 1991, Hypertension.

[30]  F. Giada,et al.  Anabolic steroid use in body builders: an echocardiographic study of left ventricle morphology and function. , 1991, International journal of sports medicine.

[31]  F. Hartgens,et al.  Influence of Anabolic Steroids on Body Composition, Blood Pressure, Lipid Profile and Liver Functions in Body Builders , 1991, International journal of sports medicine.

[32]  G. Ferenchick.  Anabolic/androgenic steroid abuse and thrombosis: is there a connection? , 1991, Medical hypotheses.

[33]  M. Proschan,et al.  The upper limit of physiologic cardiac hypertrophy in highly trained elite athletes. , 1991, The New England journal of medicine.

[34]  R. Strauss,et al.  Anabolic steroids in the athlete. , 1991, Annual review of medicine.

[35]  J L Witztum,et al.  Lipoproteins and atherogenesis. Current concepts. , 1990, JAMA.

[36]  B. Osterud,et al.  Formation and Persistence of Procoagulant and Fibrinolytic Activities in Circulation after Strenuous Physical Exercise , 1990, Thrombosis and Haemostasis.

[37]  R. Virmani,et al.  Sudden cardiac death during exercise in a weight lifter using anabolic androgenic steroids: pathological and toxicological findings. , 1990, Journal of forensic sciences.

[38]  M. Johnson,et al.  Anabolic steroid use in adolescent athletes. , 1990, Pediatric clinics of North America.

[39]  W. Yates,et al.  Illicit anabolic steroid use in athletes , 1990, The American journal of sports medicine.

[40]  M. Falduto,et al.  Glucocorticoid antagonism by exercise and androgenic-anabolic steroids. , 1990, Medicine and science in sports and exercise.

[41]  D. Ganten,et al.  Regulation of myosin heavy chain expression in the hearts of hypertensive rats by testosterone. , 1990, Circulation research.

[42]  L. Goldberg,et al.  Effect of an anabolic steroid education program on knowledge and attitudes of high school football players. , 1990, Journal of adolescent health care : official publication of the Society for Adolescent Medicine.

[43]  V. Fuster,et al.  Regression of atherosclerotic lesions by high density lipoprotein plasma fraction in the cholesterol-fed rabbit. , 1990, The Journal of clinical investigation.

[44]  S. Bowman.  Anabolic steroids and infarction. , 1990, BMJ.

[45]  K. Kugiyama,et al.  Impairment of endothelium-dependent arterial relaxation by lysolecithin in modified low-density lipoproteins , 1990, Nature.

[46]  Ferenchick Gs.  Body weight and the sensitivity of blood pressure to sodium. , 1990 .

[47]  G. Enzi,et al.  Lipid and apoprotein modifications in body builders during and after self-administration of anabolic steroids. , 1990, Metabolism: clinical and experimental.

[48]  Landry Gl,et al.  Anabolic steroid abuse , 1990 .

[49]  T. Beresford,et al.  Evidence for physical and psychological dependence on anabolic androgenic steroids in eight weight lifters. , 1990, The American journal of psychiatry.

[50]  D. Ganten,et al.  Androgen dependence and tissue specificity of renin messenger RNA expression in mice. , 1990, Journal of hypertension.

[51]  P. Henriksson,et al.  Stanozolol and experimental atherosclerosis: atherosclerotic development and blood lipids during anabolic steroid therapy of New Zealand white rabbits. , 1990, Scandinavian journal of clinical and laboratory investigation.

[52]  G. Landry,et al.  Anabolic steroid abuse , 2007 .

[53]  O. Jänne.  Androgen interaction through multiple steroid receptors. , 1990, NIDA research monograph.

[54]  Robert E. Jones,et al.  High-density lipoprotein cholesterol is not decreased if an aromatizable androgen is administered. , 1990, Metabolism: clinical and experimental.

[55]  D. Ganten,et al.  Sexual dimorphism of blood pressure in spontaneously hypertensive rats: effects of anti-androgen treatment. , 1989, Journal of hypertension.

[56]  L. Ignarro,et al.  Biological Actions and Properties of Endothelium-Derived Nitric Oxide Formed and Released From Artery and Vein , 1989, Circulation research.

[57]  V. Rickert,et al.  Anabolic steroid use by male adolescents. , 1989, Pediatrics.

[58]  L. Calabrese,et al.  Dietary influences on cardiovascular disease risk in anabolic steroid-using and nonusing bodybuilders. , 1989, Journal of the American College of Nutrition.

[59]  H. Mcgill,et al.  Heart contains receptors for dihydrotestosterone but not testosterone: Possible role in the sex differential in coronary heart disease , 1989, The Anatomical record.

[60]  H. Koenig,et al.  Polyamines mediate androgenic stimulation of calcium fluxes and membrane transport in rat heart myocytes. , 1989, Circulation research.

[61]  P. Thompson,et al.  Contrasting effects of testosterone and stanozolol on serum lipoprotein levels. , 1989, JAMA.

[62]  M. Beato.  Gene regulation by steroid hormones , 1989, Cell.

[63]  A. Catapano,et al.  Effects of Anabolic Steroids, Testosterone, and HGH on Blood Lipids and Echocardiography Parameters in Body Builders , 1989, International journal of sports medicine.

[64]  B. Raaka,et al.  The glucocorticoid antagonist 17 alpha-methyltestosterone binds to the 10 S glucocorticoid receptor and blocks agonist-mediated dissociation of the 10 S oligomer to the 4 S deoxyribonucleic acid-binding subunit. , 1989, Molecular endocrinology.

[65]  K. Friedl,et al.  Estimated prevalence of anabolic steroid use among male high school seniors. , 1988, JAMA.

[66]  D. Ganten,et al.  Gonadectomy and hormonal replacement changes systolic blood pressure and ventricular myosin isoenzyme pattern of spontaneously hypertensive rats. , 1988, Circulation research.

[67]  F. S. French,et al.  The human androgen receptor: complementary deoxyribonucleic acid cloning, sequence analysis and gene expression in prostate. , 1988, Molecular endocrinology.

[68]  K. J. Richter,et al.  Cardiomyopathy and Cerebrovascular Accident Associated With Anabolic-Androgenic Steroid Use. , 1988, The Physician and sportsmedicine.

[69]  R. Kettunen,et al.  Anabolic steroids alter the haemodynamic effects of endurance training and deconditioning in rats. , 1988, Acta physiologica Scandinavica.

[70]  The cardiovascular effects of deconditioning after endurance training in rats. , 1988, Acta physiologica Scandinavica.

[71]  R. Mcnutt,et al.  Acute myocardial infarction in a 22-year-old world class weight lifter using anabolic steroids. , 1988, The American journal of cardiology.

[72]  G. Rousseau,et al.  Evidence for sex-dependent anabolic response to androgenic steroids mediated by muscle glucocorticoid receptors in the rat. , 1988, Journal of steroid biochemistry.

[73]  J. Wilson,et al.  Androgen abuse by athletes. , 1988, Endocrine reviews.

[74]  H. Willard,et al.  Cloning of human androgen receptor complementary DNA and localization to the X chromosome. , 1988, Science.

[75]  Chawnshang Chang,et al.  Molecular cloning of human and rat complementary DNA encoding androgen receptors. , 1988, Science.

[76]  W. R. Kennedy,et al.  Drug abuse in athletes. Anabolic steroids and human growth hormone. Council on Scientific Affairs. , 1988, JAMA.

[77]  A. Goodship,et al.  The effect of exercise and anabolic steroids on the mechanical properties and crimp morphology of the rat tendon , 1988, The American journal of sports medicine.

[78]  P. Demacker,et al.  Deleterious Effects of Anabolic Steroids on Serum Lipoproteins, Blood Pressure, and Liver Function in Amateur Body Builders , 1988, International journal of sports medicine.

[79]  Lynne M. Agocs.  Strauss RH (ed): Drugs and Performance in Sports , 1987 .

[80]  P. Rämö.  Anabolic steroids alter the haemodynamic responses of the canine left ventricle. , 1987, Acta physiologica Scandinavica.

[81]  T. C. Doege,et al.  Athletes' Use and Abuse of Drugs. , 1987, The Physician and sportsmedicine.

[82]  R. Fagard,et al.  Drugs And Performance in Sports , 1987 .

[83]  L. Hirvonen,et al.  Hemodynamic effects of endurance training on canine left ventricle. , 1987, The American journal of physiology.

[84]  P. Dyment.  The adolescent athlete and ergogenic aids. , 1987, Journal of adolescent health care : official publication of the Society for Adolescent Medicine.

[85]  George A. Williams,et al.  Left ventricular diastolic function in weight lifters. , 1986, The American journal of cardiology.

[86]  G. Kamen,et al.  Effects of exercise and anabolic steroids on total and lipoprotein cholesterol concentrations in male and female rats. , 1986, Medicine and science in sports and exercise.

[87]  G. McKillop,et al.  Increased left ventricular mass in a bodybuilder using anabolic steroids. , 1986, British journal of sports medicine.

[88]  W. Schänzer,et al.  Testosterone application influences sympathetic activity of intracardiac nerves in non-trained and trained mice. , 1986, Journal of the autonomic nervous system.

[89]  B. Swynghedauw.  Developmental and functional adaptation of contractile proteins in cardiac and skeletal muscles. , 1986, Physiological reviews.

[90]  C. Lyttle,et al.  A possible mechanism in arterial wall for mediation of sex difference in atherosclerosis. , 1985, Experimental and molecular pathology.

[91]  J. Geelen,et al.  Metabolism and receptor binding of nandrolone and testosterone under in vitro and in vivo conditions. , 1985, Acta endocrinologica. Supplementum.

[92]  T. Rowland,et al.  Left ventricular size and function in body builders using anabolic steroids. , 1985, Medicine and science in sports and exercise.

[93]  J. Deslypere,et al.  Influence of age on steroid concentrations in skin and striated muscle in women and in cardiac muscle and lung tissue in men. , 1985, The Journal of clinical endocrinology and metabolism.

[94]  R. Leach,et al.  The use and abuse of anabolic steroids in Olympic-caliber athletes. , 1985, Clinical orthopaedics and related research.

[95]  M. Peach,et al.  Mechanisms of endothelium-dependent vascular smooth muscle relaxation. , 1985, Biochemical pharmacology.

[96]  G. Forbes,et al.  The effect of anabolic steroids on lean body mass: the dose response curve. , 1985, Metabolism: clinical and experimental.

[97]  J. V. Toohey,et al.  Non-medical drug use behaviour at five United States universities: a 15-year study. , 1985, Bulletin on narcotics.

[98]  M. Feraudi,et al.  Effects of training and methandrostenolone (an anabolic steroid) on energy metabolism in the guinea pig: changes in enzyme activities in gastrocnemius muscle and myocardium. , 1985, The International journal of biochemistry.

[99]  H. S. Mueller,et al.  The Thrombolysis in Myocardial Infarction (TIMI) trial. Phase I findings. , 1985, The New England journal of medicine.

[100]  G. Rovere,et al.  Anabolic steroids: A review of the literature , 2009 .

[101]  L. Burkett,et al.  Steroid Use by Athletes in a Metropolitan Area , 1984 .

[102]  A. Goldberg,et al.  High-density-lipoprotein cholesterol in bodybuilders v powerlifters. Negative effects of androgen use. , 1984, JAMA.

[103]  M. Frankle,et al.  Use of androgenic anabolic steroids by athletes. , 1984, JAMA.

[104]  T. Goodfriend,et al.  Androgen modulation of adrenal angiotensin receptors. , 1984, Science.

[105]  M J Davies,et al.  Thrombosis and acute coronary-artery lesions in sudden cardiac ischemic death. , 1984, The New England journal of medicine.

[106]  R. Zak,et al.  Growth of the heart in health and disease , 1984 .

[107]  R. Chatterton,et al.  Skeletal muscle cytosol [3H]methyltrienolone receptor binding and serum androgens: effects of hypertrophy and hormonal state. , 1983, Journal of steroid biochemistry.

[108]  M. Feraudi,et al.  Ultrastructural and Morphometric Investigations on the Effects of Training and Administration of Anabolic Steroids on the Myocardium of Guinea Pigs , 1983, International journal of sports medicine.

[109]  M. Tóth,et al.  Relative binding affinities of testosterone, 19-nortestosterone and their 5α-reduced derivatives to the androgen receptor and to other androgen-binding proteins: a suggested role of 5α-reductive steroid metabolism in the dissociation of “myotropic” and “androgenic” activities of 19-nortestosterone , 1982 .

[110]  T. Hotta,et al.  Superior sagittal sinus thrombosis associated with androgen therapy for hypoplastic anemia , 1982, Annals of neurology.

[111]  D. Goldspink,et al.  The differing responses of four muscle types to dexamethasone treatment in the rat. , 1982, The Biochemical journal.

[112]  M. Toth,et al.  Different binding of testosterone, 19-nortestosterone and their 5 alpha-reduced derivatives to the androgen receptor of the rat seminal vesicle: a step toward the understanding of the anabolic action of nortesterone. , 1982, Endokrinologie.

[113]  H. Koenig,et al.  Testosterone‐Mediated Sexual Dimorphism of the Rodent Heart: Ventricular Lysosomes, Mitochondria, and Cell Growth are Modulated by Androgens , 1982, Circulation research.

[114]  H. Weicker,et al.  Influence of Training and Anabolic Steroids on the LDH Isozyme Pattern of Skeletal and Heart Muscle Fibers of Guinea Pigs , 1982, International journal of sports medicine.

[115]  K. Horwitz,et al.  Canine vascular tissues are targets for androgens, estrogens, progestins, and glucocorticoids. , 1982, The Journal of clinical investigation.

[116]  T. Sééne,et al.  The catabolic effect of glucocorticoids on different types of skeletal muscle fibres and its dependence upon muscle activity and interaction with anabolic steroids. , 1982, Journal of steroid biochemistry.

[117]  T. M. Devlin,et al.  Textbook of biochemistry: With clinical correlations , 1982 .

[118]  R. Taylor,et al.  Collagen synthesis and content in right ventricular hypertrophy in the dog. , 1981, The American journal of physiology.

[119]  J. Gustafsson,et al.  Androgen and glucocorticoid receptors in human skeletal muscle cytosol. , 1981, Journal of steroid biochemistry.

[120]  H. Mcgill,et al.  Nuclear Uptake of Sex Steroid Hormones in the Cardiovascular System of the Baboon , 1981, Circulation research.

[121]  J. Wilson,et al.  The use and misuse of androgens. , 1980, Metabolism: clinical and experimental.

[122]  W. Santamore,et al.  Elevated collagen content in volume overload induced cardiac hypertrophy. , 1980, Journal of molecular and cellular cardiology.

[123]  L. McLain.  ANABOLIC STEROIDS AND HIGH SCHOOL STUDENTS: 150 , 1980 .

[124]  H. Mcgill,et al.  The heart is a target organ for androgen. , 1980, Science.

[125]  D. Amir,et al.  Changes Induced to Bull Spermatids and Testicular Spermatozoa by a Single Peritesticular Injection of Ethylene Dibromide , 1979 .

[126]  L. Swan,et al.  Effects of sex steroid hormones on arginine vasopressin in intact and castrated male and female rats. , 1979, Endocrinology.

[127]  M. Krieg,et al.  Demonstration of a specific androgen receptor in rat heart muscle: relationship between binding, metabolism, and tissue levels of androgens. , 1979, Endocrinology.

[128]  D. Cowan,et al.  Misuse of drugs in sport. , 1978, British journal of sports medicine.

[129]  L. Moore,et al.  Effects of Sex Hormones on Cardiovascular and Hematologic Responses to Chronic Hypoxia in Rats , 1978, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

[130]  P. Baker,et al.  Androgen-mediated sex differences of cardiovascular responses in rats. , 1978, The American journal of physiology.

[131]  O. Jänne,et al.  Progestational Activity of Natural and Synthetic Androgens , 1978 .

[132]  G. Chainy,et al.  Effects of estradiol and testosterone on the activity of pyruvate kinase of the cardiac and skeletal muscles of rats as a function of age and sex. , 1978, Biochimica et biophysica acta.

[133]  Loughton Sj,et al.  Human strength and endurance responses to anabolic steroid and training. , 1977 .

[134]  Effect of an anabolic steroid (metandienone) on central and peripheral blood flow in well-trained male athletes. , 1977, Annals of clinical research.

[135]  P. Moor,et al.  Interconversion between 17β-hydroxy-5α-androstan-3-one (5α-dihydrotestosterone) and 5α-androstane-3α,17β-diol: Tissue specificity and role of the microsomal NAD: 3α-hydroxysteroid oxidoreductase , 1977 .

[136]  F. Katz,et al.  Testosterone Effect on Renin System in Rats 1 , 1977, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

[137]  P. Ramwell,et al.  Androgen-mediated sensitivity in platelet aggregation. , 1977, The American journal of physiology.

[138]  M. Krieg,et al.  Biochemical substrate of androgenic actions at a cellular level in prostate, bulbocavernosus/levator ani and in skeletal muscle. , 1977, Acta endocrinologica. Supplementum.

[139]  R. O. Ruhling,et al.  Human strength and endurance responses to anabolic steroid and training. , 1977, The Journal of sports medicine and physical fitness.

[140]  D. Morris,et al.  Regulation of plasma levels of aldosterone and its metabolites during the latent period of aldosterone. , 1976, Journal of steroid biochemistry.

[141]  A. Banks,et al.  Anabolic steroids in athelics: crossover double-blind trial on weightlifters. , 1975, British medical journal.

[142]  M. Krieg,et al.  Binding and metabolism of testosterone and of 5-dihydrotestosterone in bulbocavernous/levator ani (BCLA) of male rats: in vivo and in vitro studies. , 1974, Journal of steroid biochemistry.

[143]  S. Rössner,et al.  Effects of oxandrolone on plasma lipoproteins and the intravenous fat tolerance in man. , 1974, Atherosclerosis.

[144]  P. Kadowitz,et al.  Androgen-induced enhancement of vascular reactivity. , 1974, Canadian journal of physiology and pharmacology.

[145]  W. Roberts,et al.  Intermyofibrillar and nuclear-myofibrillar connections in human and canine myocardium. An ultrastructural study. , 1973, Journal of molecular and cellular cardiology.

[146]  N. Bruchovsky,et al.  The effects of testosterone, 5 -dihydrotestosterone and adenosine 3',5'-monophosphate on cell proliferation and differentiation in rat prostate. , 1973, Biochimica et biophysica acta.

[147]  P. J. Salt.  Inhibition of noradrenaline uptake 2 in the isolated rat heart by steroids, clonidine and methoxylated phenylethylamines. , 1972, European journal of pharmacology.

[148]  B. Brown,et al.  The effects of exercise and dianabol upon selected performances and physiological parameters in the male rat. , 1971, Medicine and science in sports.

[149]  A. Brownie,et al.  Production of hypertensive vascular disease in the rat by methyltestosterone. , 1969, Laboratory investigation; a journal of technical methods and pathology.

[150]  C. Hall,et al.  Methylandrostenediol hypertension induced without salt excess: observations on organ changes and serum composition. , 1969, The American journal of pathology.

[151]  K. Rakušan,et al.  The growth of the muscular and collagenous parts of the rat heart in various forms of cardiomegaly , 1969, The Journal of physiology.

[152]  F. Meerson,et al.  Dynamics of nucleic acid and protein synthesis of the myocardium in compensatory hyperfunction and hypertrophy of the heart. , 1968, The American journal of cardiology.

[153]  H. Selye,et al.  The production of hypertension, nephrosclerosis and cardiac lesions by methylandrostenediol treatment in the rat. , 1954, Endocrinology.

[154]  Robert L. Swain,et al.  National Association of Boards of Pharmacy , 1954 .

[155]  K. W. Thompson.  TESTOSTERONE FOR TREATMENT OF THE EUNUCHOID STATE , 1943 .

[156]  P. White.  Enlargement of the Heart , 1941 .

[157]  T. R. Harrison,et al.  THE EFFECT OF VARIOUS STEROL DERIVATIVES ON THE BLOOD PRESSURE OF THE RAT , 1940 .

[158]  N. J. Heckel,et al.  MALE SEX HORMONE: CLINICAL APPLICATION , 1939 .

[159]  J. Parkinson.  ENLARGEMENT OF THE HEART , 1936 .

[160]  R. Greene.  The Male Sex Hormone , 1946, Nature.

[161]  P. L. Krohn.  Female Sex Hormones , 1932, Science.